Ausgabe 2/2015
Special Issue: Cardiac Amyloidosis; Guest Editors: Mat Maurer, Rodney Falk, and Claudio Rapezzi. Also Featuring: Additional Reviews in Heart Failure
Inhalt (11 Artikel)
Cardiac amyloidosis: the great pretender
Claudio Rapezzi, Massimiliano Lorenzini, Simone Longhi, Agnese Milandri, Christian Gagliardi, Ilaria Bartolomei, Fabrizio Salvi, Mathew S. Maurer
Cardiovascular magnetic resonance for amyloidosis
Marianna Fontana, Robin Chung, Philip N. Hawkins, James C. Moon
Nuclear imaging for cardiac amyloidosis
Walter Noordzij, Andor W. J. M. Glaudemans, Simone Longhi, Riemer H. J. A. Slart, Massimiliano Lorenzini, Bouke P. C. Hazenberg, Claudio Rapezzi
Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs
Adam Castaño, Brian M. Drachman, Daniel Judge, Mathew S. Maurer
Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment
Brendan N. Putko, Kevin Wen, Richard B. Thompson, John Mullen, Miriam Shanks, Haran Yogasundaram, Consolato Sergi, Gavin Y. Oudit
Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis
Chirag Bavishi, Saurav Chatterjee, Sameer Ather, Dipen Patel, Franz H. Messerli
Next-generation endomyocardial biopsy: the potential of confocal and super-resolution microscopy
David J. Crossman, Peter N. Ruygrok, Yu Feng Hou, Christian Soeller
Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential
Shuchita Gupta, Aman Amanullah
Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart
Alexander T. Akhmedov, Vitalyi Rybin, José Marín-García